Recruiting Clinical Trials

Displaying 11 - 20 of 238 result(s)
Study Title Condition Phase Location
A Non-interventional Study Evaluating Kesimpta® (Ofatumumab) Treatment Effects in Patients With Relapsing Multiple Sclerosis Transitioning From Other Therapies [KAIROS] Multiple Sclerosis Not Given
  • Country: 
    Germany
Long Term Special Drug Use-results Surveillance for Mayzent in SPMS Patients (Prevention of Relapses and Delay of Progression of Physical Disability in Secondary Progressive Multiple Sclerosis) Secondary Progressive Multiple Sclerosis (SPMS) Not Given
  • Country: 
    Japan
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase III Study to Evaluate the Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients IgA Nephropathy Phase 3
  • Country: 
    United States
  • Country: 
    Argentina
  • Country: 
    Australia
  • Country: 
A Multi-center, Randomized, Double-blind, Parallel-group, 20-week Dose-finding Study to Evaluate Efficacy, Safety, and Tolerability of XXB750 in Patients With Resistant Hypertension Resistant Hypertension Phase 2
  • Country: 
    United States
  • Country: 
    Australia
Special Drug Use-results Surveillance of Tabrecta Tablets (MET Exon 14 Skipping Mutation-positive Unresectable Advanced/Recurrent Non-small Cell Lung Cancer) Non-small Cell Lung Cancer Not Given
  • Country: 
    Japan
A Phase Ib Dose Finding Study Assessing Safety and Activity of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Extensive Stage Small Cell Lung Cancer (ES-SCLC) in Combination With Carboplatin, Etoposide and Tislelizumab in Induction and With Tislelizumab in M ... Extensive Stage Small Cell Lung Cancer Phase 1
  • Country: 
    France
  • Country: 
    Spain
A Randomized, Placebo-controlled, Subject and Investigator Blinded Study Investigating the Safety, Tolerability and Preliminary Efficacy of 8-week Treatment With Intra-articular LRX712 to Regenerate Articular Cartilage in Patients With Mild/Moderate ... Osteoarthritis (OA) Phase 2
  • Country: 
    Austria
  • Country: 
    Netherlands
A Real-world, Prospective, Multicenter Study to Assess the Safety and Effectiveness of Secukinumab (Cosentyx®) in Patients Aged 6 to Less Than 18 Years With Moderate to Severe Chronic Plaque Psoriasis in China Moderate to Severe Chronic Plaque Psoriasis Not Given
  • Country: 
    China
Special Drug Use-results Surveillance of Scemblix Tablets (Resistant or Intolerant Chronic Myeloid Leukemia , CABL001A1401) Chronic Myeloid Leukemia Not Given
  • Country: 
    Japan
A Phase IIIb, Multi-center, Open-label, Randomized Study of Tolerability and Efficacy of Oral Asciminib Versus Nilotinib in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase. Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Phase 3
  • Country: 
    Czech Republic
  • Country: 
    France
  • Country: 
    Germany
  • Country: